Citations (108)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Max J. Gordon & Jason R. Westin. (2022) Fitting double-hit lymphoma into the aggressive lymphoma spectrum: a square peg in a round hole?. Leukemia & Lymphoma 63:5, pages 1034-1044.
Read now
Read now
Adam S. Zayac & Adam J. Olszewski. (2020) Burkitt lymphoma: bridging the gap between advances in molecular biology and therapy. Leukemia & Lymphoma 61:8, pages 1784-1796.
Read now
Read now
Dominic P. Decker, Pamela C. Egan, Adam S. Zayac, Diana O. Treaba & Adam J. Olszewski. (2020) Treatment strategies and risk of central nervous system recurrence in high-grade B-cell and Burkitt lymphoma. Leukemia & Lymphoma 61:1, pages 198-201.
Read now
Read now
Heather A. Personett, Erin F. Barreto, Kristen B. McCullough, Ross Dierkhising, Nelson Leung & Thomas M. Habermann. (2019) Impact of early rasburicase on incidence of clinical tumor lysis syndrome in lymphoma. Leukemia & Lymphoma 60:9, pages 2271-2277.
Read now
Read now
Greg Hapgood, Janey M. Stone, Diana Zannino, Anup George, Paula Marlton, Henry Miles Prince, Chi-Hung Hui, Ian Prosser, Ian D. Lewis, Kenneth Bradstock & John F. Seymour. (2019) A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma. Leukemia & Lymphoma 60:4, pages 904-911.
Read now
Read now
Domenico Albano, Giovanni Bosio, Alessandro Re, Chiara Pagani, Raffaele Giubbini & Francesco Bertagna. (2019) Metabolic behavior and prognostic value of early and end of treatment 18F-FDG PET/CT in adult Burkitt’s lymphoma: the role of Deauville and IHP criteria. Leukemia & Lymphoma 60:2, pages 326-333.
Read now
Read now
Claudia M. Wever, Dominique Geoffrion, Bruno M. Grande, Stephen Yu, Miguel Alcaide, Maryse Lemaire, Yasser Riazalhosseini, Josée Hébert, Christina Gavino, Donald C. Vinh, Tina Petrogiannis-Haliotis, Svetlana Dmitrienko, Koren K. Mann, Ryan D. Morin & Nathalie A. Johnson. (2018) The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples. Leukemia & Lymphoma 59:9, pages 2159-2174.
Read now
Read now
Massimo Dozzo, Francesca Carobolante, Pietro Maria Donisi, Annamaria Scattolin, Elena Maino, Rosaria Sancetta, Piera Viero & Renato Bassan. (2017) Burkitt lymphoma in adolescents and young adults: management challenges. Adolescent Health, Medicine and Therapeutics 8, pages 11-29.
Read now
Read now
Binay Kumar Shah & Nibash Budhathoki. (2016) Second primary malignancy in Burkitt's lymphoma. Acta Oncologica 55:3, pages 396-398.
Read now
Read now
Caterina Ieranò, Arup Chakraborty, Alina Nicolae, Julian Bahr, Zhirong Zhan, Stefania Pittaluga, Susan Bates & Robert Robey. (2013) Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitors. Cell Cycle 12:17, pages 2829-2838.
Read now
Read now
Yvette L. Kasamon, Robert A. Brodsky, Michael J. Borowitz, Richard F. Ambinder, Pamela A. Crilley, Steve Y. Cho, Hua-ling Tsai, B. Douglas Smith, Douglas E. Gladstone, Hetty E. Carraway, Carol Ann Huff, William H. Matsui, Javier Bolaños-Meade, Richard J. Jones & Lode J. Swinnen. (2013) Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia. Leukemia & Lymphoma 54:3, pages 483-490.
Read now
Read now
Maria Luisa Moleti, Anna Maria Testi, Fiorina Giona, Luigi Malandruccolo, Edoardo Pescarmona, Pietro Martino, Francesca Paoloni, Walter Barberi, Giovanna Palumbo, Franco Mandelli & Robin Foa. (2007) CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: A 15-year monocentric experience. Leukemia & Lymphoma 48:3, pages 551-559.
Read now
Read now
Lisa A. Kujawski, Walter L. Longo, Eliot C. Williams, Nancy J. Turman, Nancy Brandt, Deane F. Mosher, Jens C. Eickhoff & Brad S. Kahl. (2007) A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas. Cancer Investigation 25:2, pages 87-93.
Read now
Read now
Eric Jacobsen & Ann LaCasce. (2006) Update on the therapy of highly aggressive non-Hodgkin’s lymphoma. Expert Opinion on Biological Therapy 6:7, pages 699-708.
Read now
Read now
John Gerecitano & David J Straus. (2006) Treatment of Burkitt lymphoma in adults. Expert Review of Anticancer Therapy 6:3, pages 373-381.
Read now
Read now
Articles from other publishers (93)
Juan Pablo Alderuccio, Lakshmi Nayak & Kate Cwynarski. (2023) How I treat secondary CNS involvement by aggressive lymphomas. Blood 142:21, pages 1771-1783.
Crossref
Crossref
P. Connor Johnson, Netana H. Markovitz, Alisha Yi, Nora Horick, Richard A. Newcomb, Katherine Cronin, David Schneider, Ryan D. Nipp & Areej El-Jawahri. (2023) Clinical Outcomes and Health Care Utilization in Patients With Burkitt Lymphoma. JCO Oncology Practice.
Crossref
Crossref
Giovanna Tagliabue, Viviana Perotti, Sabrina Fabiano, Andrea Tittarelli, Giulio Barigelletti, Paolo Contiero, Walter Mazzucco, Mario Fusco, Ettore Bidoli, Massimo Vicentini, Maria Teresa Pesce & Fabrizio Stracci. (2023) Comparison between two cancer registry quality check systems: functional features and differences in an Italian network of cancer registries dataset. Frontiers in Oncology 13.
Crossref
Crossref
Sugeeth MT, Geetha Narayanan, Anoop TM, Sreejith G Nair, Prakash NP, Jagathnath Krishna KM & Rekha A Nair. (2023) Treatment Outcome of Burkitt's Lymphoma in Adolescents and Adults: A Retrospective Study. Indian Journal of Medical and Paediatric Oncology.
Crossref
Crossref
Adam J. Olszewski, Habibe Kurt & Andrew M. Evens. (2022) Defining and treating high-grade B-cell lymphoma, NOS. Blood 140:9, pages 943-954.
Crossref
Crossref
Wei Sang, Dongyun Tu, Meng Zhang, Yuanyuan Qin, Wenjing Yin, Xuguang Song, Cai Sun, Dongmei Yan, Xiangmin Wang, Lingyu Zeng, Zhenyu Li, Kailin Xu & Linyan Xu. (2022)
l
‐Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein−Barr virus‐positive Burkitt lymphoma
. Journal of Biochemical and Molecular Toxicology 36:8.
Crossref
Crossref
Ricardo Ferrari Pereira, Geovanne Pedro Mauro, Carolina Trindade Mello Medici, Lucas Coelho Casimiro & Eduardo Weltman. (2021) Radiotherapy in Adult Burkitt Lymphoma: A Retrospective Analysis in a Large University Center. Indian Journal of Hematology and Blood Transfusion 38:3, pages 508-515.
Crossref
Crossref
Megan Fleming, Ying Huang, Emily Dotson, David A. Bond, John Reneau, Narendranath Epperla, Lapo Alinari, Jonathan Brammer, Beth Christian, Robert A. Baiocchi, Kami Maddocks & Yazeed Sawalha. (2022) Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective study. Therapeutic Advances in Hematology 13, pages 204062072211129.
Crossref
Crossref
Michael J. Buege, Phuong H. Dao, Esther Drill, Andréa LeVoir, Terry Pak, Tim J. Peterson & David J. Straus. (2021) IVAC With or Without Rituximab for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas: Real-World Experience in the Modern Era. Clinical Lymphoma Myeloma and Leukemia 21:12, pages 873-878.
Crossref
Crossref
Ana M. Della Rocca, Letícia P. Leonart, Vinicius L. Ferreira, Fernanda S. Tonin, Giovanna Steffenello-Durigon, Joanita A.G. Del Moral, Fernando Fernandez-Llimos & Roberto Pontarolo. (2021) Chemotherapy Treatments for Burkitt Lymphoma: Systematic Review of Interventional Studies. Clinical Lymphoma Myeloma and Leukemia 21:8, pages 514-525.
Crossref
Crossref
Juan Pablo Alderuccio, Adam J. OlszewskiAndrew M. EvensGraham P. CollinsAlexey V. DanilovMark Bower, Deepa JagadeeshCatherine Zhu, Amy SperlingSeo-Hyun Kim, Ryan VacaCatherine WeiSuchitra Sundaram, Nishitha ReddyAlessia Dalla PriaChristopher D’Angelo, Umar FarooqDavid A. Bond, Stephanie BergMichael C. ChurnetskiAmandeep Godara, Nadia Khan, Yun Kyong ChoiShireen KassamMaryam Yazdy, Emma RabinovichFrank A. Post, Gaurav Varma, Reem KarmaliMadelyn Burkart, Peter MartinAlbert RenAyushi ChauhanCatherine Diefenbach, Allandria Straker-EdwardsAndreas KleinKristie A. BlumKirsten Marie BoughanAgrima Mian, Bradley M. Haverkos, Victor M. Orellana-NoiaVaishalee P. KenkreAdam Zayac, Seth M. Maliske, Narendranath Epperla, Paolo CaimiScott E. SmithManali KamdarParameswaran VenugopalTatyana A. FeldmanDaniel RectorStephen D. Smith, Andrzej StadnikCraig A. PortellYong LinSeema Naik, Silvia Montoto, Izidore S. Lossos & Kate Cwynarski. (2021) HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis. Blood Advances 5:14, pages 2852-2862.
Crossref
Crossref
Gunjan S DalalDrDr, Jyoti JainDrDrAtul Singh RajputDrDr. (2021) INCREASINGLY COMMON PRESENTATION OF EXTRANODAL BURKITTS LYMPHOMA WITH SURPRISINGLY RAISED PLEURAL/ASCITIC FLUID ADENOSINE DEAMINASE LEVELS. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 48-51.
Crossref
Crossref
Coen J. Lap, Samah Nassereddine & Kieron Dunleavy. (2021) Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma. Current Treatment Options in Oncology 22:7.
Crossref
Crossref
William Sergi, Tiziana Rita Lucia Marchese, Ivan Botrugno, Arturo Baglivo & Marcello Spampinato. (2021) Primary ovarian Burkitt's lymphoma presentation in a young woman: A case report. International Journal of Surgery Case Reports 83, pages 105904.
Crossref
Crossref
Andrew M. Evens. (2021) Burkitt Lymphoma. Oncology Times 43:7, pages 1,10-11.
Crossref
Crossref
Adam J. Olszewski, Lasse H. Jakobsen, Graham P. Collins, Kate Cwynarski, Veronika Bachanova, Kristie A. Blum, Kirsten M. Boughan, Mark Bower, Alessia Dalla Pria, Alexey Danilov, Kevin A. David, Catherine Diefenbach, Fredrik Ellin, Narendranath Epperla, Umar Farooq, Tatyana A. Feldman, Alina S. Gerrie, Deepa Jagadeesh, Manali Kamdar, Reem Karmali, Shireen Kassam, Vaishalee P. Kenkre, Nadia Khan, Seo-Hyun Kim, Andreas K. Klein, Izidore S. Lossos, Matthew A. Lunning, Peter Martin, Nicolas Martinez-Calle, Silvia Montoto, Seema Naik, Neil Palmisiano, David Peace, Elizabeth H. Phillips, Tycel J. Phillips, Craig A. Portell, Nishitha Reddy, Anna Santarsieri, Maryam Sarraf Yazdy, Knut B. Smeland, Scott E. Smith, Stephen D. Smith, Suchitra Sundaram, Adam S. Zayac, Xiao-Yin Zhang, Catherine Zhu, Chan Y. Cheah, Tarec C. El-Galaly & Andrew M. Evens. (2021) Burkitt Lymphoma International Prognostic Index. Journal of Clinical Oncology 39:10, pages 1129-1138.
Crossref
Crossref
Heather P. May, Erin F. Barreto, Kristin C. Mara, Kristen B. McCullough, Mrinal S. Patnaik, Nelson Leung & Thomas M. Habermann. (2021) Risk for Significant Kidney Function Decline After Acute Kidney Injury in Adults With Hematologic Malignancy. Kidney International Reports 6:4, pages 1050-1057.
Crossref
Crossref
Adam S. Zayac, Andrew M. Evens, Alexey Danilov, Stephen D. Smith, Deepa Jagadeesh, Lori A. Leslie, Catherine Wei, Seo-Hyun Kim, Seema Naik, Suchitra Sundaram, Nishitha Reddy, Umar Farooq, Vaishalee P. Kenkre, Narendranath Epperla, Kristie A. Blum, Nadia Khan, Daulath Singh, Juan P. Alderuccio, Amandeep Godara, Maryam Sarraf Yazdy, Catherine Diefenbach, Emma Rabinovich, Gaurav Varma, Reem Karmali, Yusra Shao, Asaad Trabolsi, Madelyn Burkart, Peter Martin, Sarah Stettner, Ayushi Chauhan, Yun Kyong Choi, Allandria Straker-Edwards, Andreas Klein, Michael C. Churnetski, Kirsten M. Boughan, Stephanie Berg, Bradley M. Haverkos, Victor M. Orellana-Noia, Christopher D'Angelo, David A. Bond, Seth M. Maliske, Ryan Vaca, Gabriella Magarelli, Amy Sperling, Max J. Gordon, Kevin A. David, Malvi Savani, Paolo Caimi, Manali Kamdar, Matthew A Lunning, Neil Palmisiano, Parameswaran Venugopal, Craig A. Portell, Veronika Bachanova, Tycel Phillips, Izidore S. Lossos & Adam J. Olszewski. (2021) Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study. Haematologica 106:7, pages 1932-1942.
Crossref
Crossref
Andrew M. Evens, Alexey DanilovDeepa JagadeeshAmy SperlingSeo-Hyun Kim, Ryan VacaCatherine WeiDaniel RectorSuchitra SundaramNishitha ReddyYong LinUmar FarooqChristopher D'AngeloDavid A. Bond, Stephanie BergMichael C. ChurnetskiAmandeep Godara, Nadia KhanYun Kyong ChoiMaryam Yazdy, Emma RabinovichGaurav Varma, Reem KarmaliAgrima Mian, Malvi Savani, Madelyn Burkart, Peter MartinAlbert RenAyushi ChauhanCatherine DiefenbachAllandria Straker-EdwardsAndreas K. KleinKristie A. BlumKirsten Marie BoughanScott E. Smith, Brad M. Haverkos, Victor M. Orellana-NoiaVaishalee P. KenkreAdam Zayac, Jeremy RamdialSeth M. Maliske, Narendranath Epperla, Parameswaran VenugopalTatyana A. FeldmanStephen D. SmithAndrzej StadnikKevin A. DavidSeema NaikIzidore S. Lossos, Matthew A. LunningPaolo CaimiManali KamdarNeil Palmisiano, Veronika BachanovaCraig A. Portell, Tycel Phillips, Adam J. Olszewski & Juan Pablo Alderuccio. (2021) Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers. Blood 137:3, pages 374-386.
Crossref
Crossref
Pamela Abdayem, Jean-Marie Michot, Valérie Camara-Clayette, Yegor Vassetsky & Vincent Ribrag. 2021. Acute Leukemias. Acute Leukemias
249
275
.
Digamber Chaubey, Sandip Kumar Rahul, Sujit Kumar & Ramdhani Yadav. (2021) Diffuse Involvement of Small Bowel in Burkitt’s Lymphoma with Intussusception. Indian Journal of Medical and Paediatric Oncology 41:06, pages 899-900.
Crossref
Crossref
Mark Roschewski, Kieron Dunleavy, Jeremy S. Abramson, Bayard L. Powell, Brian K. Link, Prapti Patel, Philip J. Bierman, Deepa Jagadeesh, Ronald T. Mitsuyasu, David Peace, Peter R. Watson, Wahid T. Hanna, Christopher Melani, Andrea N. Lucas, Seth M. Steinberg, Stefania Pittaluga, Elaine S. Jaffe, Jonathan W. Friedberg, Brad S. Kahl, Richard F. Little, Nancy L. Bartlett, Michelle A. Fanale, Ariela Noy & Wyndham H. Wilson. (2020) Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma. Journal of Clinical Oncology 38:22, pages 2519-2529.
Crossref
Crossref
Philippos Apolinario Costa, Brandon S Needelman, Youley Tjendra & James E Hoffman. (2020) High-grade B-cell lymphoma with MYC and BCL6 rearrangements presenting as a cervical mass. BMJ Case Reports 13:8, pages e235451.
Crossref
Crossref
Elizabeth H. Phillips, Catherine Burton, Amy A. Kirkwood, Sharon Barrans, Anthony Lawrie, Simon Rule, Russell Patmore, Ruth Pettengell, Kirit M. Ardeshna, Silvia Montoto, Shankara Paneesha, Laura Clifton‐Hadley, David C. Linch & Andrew K. McMillan. (2020) Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial. eJHaem 1:1, pages 133-141.
Crossref
Crossref
Lasse H. Jakobsen, Fredrik Ellin, Knut B. Smeland, Tove Wästerlid, Jacob H. Christensen, Judit M. Jørgensen, Pär L. Josefsson, Andreas K. Øvlisen, Harald Holte, Yngvild N. Blaker, Jacob H. Grauslund, Jon Bjørn, Daniel Molin, Ingemar Lagerlöf, Karin E. Smedby, Katherine Colvin, Gita Thanarajasingam, Matthew J. Maurer, Thomas M. Habermann, Kevin W. Song, Katie Y. Zhu, Alina S. Gerrie, Chan Y. Cheah & Tarec C. El‐Galaly. (2020) Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients. British Journal of Haematology 189:4, pages 661-671.
Crossref
Crossref
Jielun Lu, Huo Tan, Bo Li, Shuyi Chen, Lihua Xu & Yawei Zou. (2019) Status and prognostic nomogram of patients with Burkitt lymphoma. Oncology Letters.
Crossref
Crossref
Thomas J Nowak, Aaron H Lorge, Lisa E Rein, Angela M Canadeo, Joel P Frank, Lisa C Samanas, Angela M Urmanski & Ehab L Atallah. (2018) Implementation and evaluation of high-dose methotrexate administration guidelines. Journal of Oncology Pharmacy Practice 25:7, pages 1675-1681.
Crossref
Crossref
Jennifer L. Crombie & Ann S. LaCasce. (2019) Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders. Frontiers in Oncology 9.
Crossref
Crossref
Carla Casulo & Jonathan W. Friedberg. (2018) Burkitt lymphoma- a rare but challenging lymphoma. Best Practice & Research Clinical Haematology 31:3, pages 279-284.
Crossref
Crossref
Pilar Miralles, José Tomás Navarro, Juan Berenguer, José Gómez Codina, Mi Kwon, David Serrano, José Luis Díez-Martín, Salvador Villà, Rafael Rubio, Javier Menárguez & José-María Ribera Santasusana. (2018) Recomendaciones de GESIDA/PETHEMA sobre el diagnóstico y tratamiento de los linfomas en pacientes infectados por el virus de la inmunodeficiencia humana. Medicina Clínica 151:1, pages 39.e1-39.e17.
Crossref
Crossref
Pilar Miralles, José Tomás Navarro, Juan Berenguer, José Gómez Codina, Mi Kwon, David Serrano, José Luis Díez-Martín, Salvador Villà, Rafael Rubio, Javier Menárguez & José-María Ribera Santasusana. (2018) GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus. Medicina Clínica (English Edition) 151:1, pages 39.e1-39.e17.
Crossref
Crossref
Katie Y. Zhu, Kevin W. Song, Joseph M. Connors, Heather Leitch, Michael J. Barnett, Khaled Ramadan, Graham W. Slack, Yasser Abou Mourad, Donna L. Forrest, Donna E. Hogge, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Maryse M. Power, David S. Sanford, Heather J. Sutherland, Tracy Tucker, Cynthia L. Toze, Laurie H. Sehn, Raewyn Broady & Alina S. Gerrie. (2018)
Excellent real‐world outcomes of adults with Burkitt lymphoma treated with
CODOX
‐M/
IVAC
plus or minus rituximab
. British Journal of Haematology 181:6, pages 782-790.
Crossref
Crossref
L. E. M. Oosten, M. E. D. Chamuleau, F. W. Thielen, L. C. de Wreede, C. Siemes, J. K. Doorduijn, O. S. Smeekes, M. J. Kersten, L. Hardi, J. W. Baars, A. M. P. Demandt, W. B. C. Stevens, M. Nijland, G. W. van Imhoff, R. Brouwer, C. A. Uyl-de Groot, P. M. Kluin, D. de Jong & H. Veelken. (2017) Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens. Annals of Hematology 97:2, pages 255-266.
Crossref
Crossref
Michael Oertel, Oliver Micke & Hans Theodor Eich. 2018. Radiation Oncology. Radiation Oncology
1
6
.
Justine M. KahnNmazuo W. OzuahKieron DunleavyTara O. HendersonKara Kelly & Ann LaCasce. (2017) Adolescent and young adult lymphoma: collaborative efforts toward optimizing care and improving outcomes. Blood Advances 1:22, pages 1945-1958.
Crossref
Crossref
Meenu Angi, Vandana Kamath, S. Yuvarani, J. Meena, Usha Sitaram, Marie Therese Manipadam, Sukesh Nair, Abhijeet Ganapule, N.A. Fouzia, Aby Abraham, Auro Viswabandya, B. Poonkuzhali, Biju George, Vikram Mathews, Alok Srivastava & Vivi M. Srivastava. (2017) The t(8;14)(q24.1;q32) and its variant translocations: A study of 34 cases. Hematology/Oncology and Stem Cell Therapy 10:3, pages 126-134.
Crossref
Crossref
Arnold S. Freedman & Ann S. LaCasce. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
19
.
Pierre Sesques & Nathalie A. Johnson. (2017) Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements. Blood 129:3, pages 280-288.
Crossref
Crossref
Auayporn Nademanee. 2017. Management of Lymphomas: A Case-Based Approach. Management of Lymphomas: A Case-Based Approach
123
137
.
Ariela Noy, Jeannette Y. LeeEthel CesarmanRichard AmbinderRobert BaiocchiErin ReidLee Ratner, Nina Wagner-Johnston & Lawrence Kaplan. (2015) AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood 126:2, pages 160-166.
Crossref
Crossref
Haowei Sun, Kerry J. Savage, Aly Karsan, Graham W. Slack, Randy D. Gascoyne, Cynthia L. Toze, Laurie H. Sehn, Yasser Abou Mourad, Michael J. Barnett, Raewyn C. Broady, Joseph M. Connors, Donna L. Forrest, Alina S. Gerrie, Donna E. Hogge, Sujaatha Narayanan, Thomas J. Nevill, Stephen H. Nantel, Maryse M. Power, Heather J. Sutherland, Diego Villa, John D. Shepherd & Kevin W. Song. (2015) Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation. Clinical Lymphoma Myeloma and Leukemia 15:6, pages 341-348.
Crossref
Crossref
Daniel H. Johnson, Thomas Reske & Marco Ruiz. (2015) Case Report and Review of Immunodeficiency-Associated Burkitt Lymphoma. Clinical Lymphoma Myeloma and Leukemia 15:6, pages e121-e125.
Crossref
Crossref
A. Prica, A. Pratzer, M. Cheung, K. Thompson, E. Piliotis, N. L. Berinstein, K. Imrie, R. Pradhan, A. Vyas, Z. Ghorab, D. Good, L. Zhang & R. Buckstein. (2015) Rituximab Improves Overall Survival in Patients Treated with CODOX-M/IVAC for Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and BL (BCL-U): A Single Center Experience and Review of the Literature. Journal of Cancer Therapy 06:01, pages 1-11.
Crossref
Crossref
Estrella Carrillo-Cruz, Víctor A. Marín-Oyaga, María Solé Rodríguez, Isabel Borrego-Dorado, Fátima de la Cruz Vicente, Eduardo Quiroga Cantero, Marina Manzanares Pérez, Francisco J. Capote, María J. Ramírez Sánchez, Ildefonso Espigado Tocino, Herminia Pérez-Vega, Ricardo Vázquez-Albertino & Jose A. Pérez-Simón. (2015) Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma. European Journal of Haematology 94:1, pages 23-30.
Crossref
Crossref
Caron Jacobson & Ann LaCasce. (2014) How I treat Burkitt lymphoma in adults. Blood 124:19, pages 2913-2920.
Crossref
Crossref
Swarupa Mitra, Anurag Mehta, Sunil Kumar Gupta, Anila Sharma, A. Robert Louis, Manoj Kumar Sharma, Upasna Saxena, David K. Simson & Abhinav Dewan. (2017) Primary Gastric Burkitt's Lymphoma. Rare Tumors 6:4, pages 128-131.
Crossref
Crossref
Elroy P Weledji, Marcelin N Ngowe & John S Abba. (2014) Burkitt?s lymphoma masquerading as appendicitis ? two case reports and review of the literature. World Journal of Surgical Oncology 12:1, pages 187.
Crossref
Crossref
Andrew E. Place, Natasha N. Frederick & Stephen E. Sallan. (2014) Therapeutic approaches to haematological malignancies in adolescents and young adults. British Journal of Haematology 164:1, pages 3-14.
Crossref
Crossref
A.F. Herrera, A.F. Herrera, D.L. Longo & D.L. Longo. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
A.M. Evens, K.R. Carson, J. Kolesar, C. Nabhan, I. Helenowski, N. Islam, B. Jovanovic, P.M. Barr, P.F. Caimi, S.A. Gregory & L.I. Gordon. (2013) A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma. Annals of Oncology 24:12, pages 3076-3081.
Crossref
Crossref
T. Wästerlid, P.N. Brown, O. Hagberg, H. Hagberg, L.M. Pedersen, F. D'Amore & M. Jerkeman. (2013) Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group. Annals of Oncology 24:7, pages 1879-1886.
Crossref
Crossref
Ian D. Norton & Vipul Aggarwal. 2013. Gastrointestinal Endoscopy in the Cancer Patient. Gastrointestinal Endoscopy in the Cancer Patient
355
366
.
Saurabh Chhabra & Ginna G. Laport. 2013. The BMT Data Book. The BMT Data Book
90
112
.
Dieter Hoelzer & Thomas Burmeister. 2013. Lymphoma. Lymphoma
231
242
.
Peter M. Mwamba & Scot C. Remick. 2013. Burkitt’s Lymphoma. Burkitt’s Lymphoma
131
150
.
Shuvomoy Banerjee, Hem Chandra Jha, Qiliang Cai & Erle S. Robertson. 2013. Burkitt’s Lymphoma. Burkitt’s Lymphoma
175
209
.
David C. Linch. (2012) Burkitt lymphoma in adults. British Journal of Haematology 156:6, pages 693-703.
Crossref
Crossref
Lawrence D. Kaplan. (2012) HIV-associated lymphoma. Best Practice & Research Clinical Haematology 25:1, pages 101-117.
Crossref
Crossref
Elizabeth M Molyneux, Rosemary Rochford, Beverly Griffin, Robert Newton, Graham Jackson, Geetha Menon, Christine J Harrison, Trijn Israels & Simon Bailey. (2012) Burkitt's lymphoma. The Lancet 379:9822, pages 1234-1244.
Crossref
Crossref
Adam M. Petrich, Joseph A. Sparano & Samir Parekh. (2012) Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma. Advances in Hematology 2012, pages 1-8.
Crossref
Crossref
Gaetano Corazzelli, Ferdinando Frigeri, Filippo Russo, Chiara Frairia, Manuela Arcamone, Gennaro Esposito, Annarosaria De Chiara, Emanuela Morelli, Gaetana Capobianco, Cristina Becchimanzi, Francesco Volzone, Mariangela Saggese, Giampaolo Marcacci, Rosaria De Filippi, Umberto Vitolo & Antonio Pinto. (2012) RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ?unclassifiable? highly aggressive B-cell lymphoma. British Journal of Haematology 156:2, pages 234-244.
Crossref
Crossref
Ilseon Hwang, Heounjeong Go, Yoon Kyung Jeon, Young Hyeh Ko, Dok Hyun Yoon, Cheolwon Suh, Joo Ryung Huh, Hyangsin Lee, Minchan Gil & Chan-Sik Park. (2011) Expression of JL1 in Burkitt lymphoma is associated with improved overall survival. Virchows Archiv 459:4, pages 353-359.
Crossref
Crossref
J.A. Barnes, A.S. LaCasce, Y. Feng, C.E. Toomey, D. Neuberg, J.S. Michaelson, E.P. Hochberg & J.S. Abramson. (2011) Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis. Annals of Oncology 22:8, pages 1859-1864.
Crossref
Crossref
Nathan Fowler & Peter McLaughlin. 2011. Advances in Malignant Hematology. Advances in Malignant Hematology
274
295
.
Deborah A. Thomas, Susan O’Brien, Stefan Faderl, John T. ManningJrJr, Jorge Romaguera, Luis Fayad, Fredrick Hagemeister, Jeffrey Medeiros, Jorge Cortes & Hagop Kantarjian. (2010) Burkitt Lymphoma and Atypical Burkitt or Burkitt-like Lymphoma: Should These be Treated as Different Diseases?. Current Hematologic Malignancy Reports 6:1, pages 58-66.
Crossref
Crossref
Amanda ZompDominic A. Solimando & J. Aubrey Waddell. (2011) CODOX-M/IVAC for non-Hodgkin Lymphomas. Hospital Pharmacy 46:2, pages 91-100.
Crossref
Crossref
Kevin A. David, Mark Roberts, LoAnn C. Peterson & Andrew M. Evens. 2011. Adult Acute Lymphocytic Leukemia. Adult Acute Lymphocytic Leukemia
175
210
.
Michele Bibas, Susanna Grisetti, Lucia Alba, Giovanna Picchi, Franca Del Nonno & Andrea Antinori. (2010) Patient With HIV-Associated Plasmablastic Lymphoma Responding to Bortezomib Alone and in Combination With Dexamethasone, Gemcitabine, Oxaliplatin, Cytarabine, and Pegfilgrastim Chemotherapy and Lenalidomide Alone. Journal of Clinical Oncology 28:34, pages e704-e708.
Crossref
Crossref
Aliyah R. Sohani & Robert Paul Hasserjian. (2010) Diagnosis of Burkitt Lymphoma and Related High-Grade B-Cell Neoplasms. Surgical Pathology Clinics 3:4, pages 1035-1059.
Crossref
Crossref
Dai Maruyama, Takashi Watanabe, Akiko Miyagi Maeshima, Junko Nomoto, Hirokazu Taniguchi, Teruhisa Azuma, Masakazu Mori, Wataru Munakata, Sung-Won Kim, Yukio Kobayashi, Yoshihiro Matsuno & Kensei Tobinai. (2010) Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL. International Journal of Hematology 92:5, pages 732-743.
Crossref
Crossref
Julie M. Vose. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies
494
502
.
Ariela Noy. (2010) Controversies in the treatment of Burkitt lymphoma in AIDS. Current Opinion in Oncology 22:5, pages 443-448.
Crossref
Crossref
Ian MagrathG Mead. 2010. The Lymphoid Neoplasms 3ed. The Lymphoid Neoplasms 3ed
1220
1231
.
Ning-jing Lin, Wen Zheng, Yun-tao Zhang, Xiao-pei Wang, Yu-qin Song, Yan Xie, Mei-feng Tu, Ling-yan Ping & Jun Zhu. (2010) Clinical analysis of 13 cases with Burkitt lymphoma or Burkitt-like lymphoma. Clinical Oncology and Cancer Research 7:2, pages 110-115.
Crossref
Crossref
Ami Albihn, John Inge Johnsen & Marie Arsenian Henriksson. 2010.
163
224
.
Li Hsiao C.Robert H. CollinsJr.Jr.. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease
445
460.e5
.
Claudio Mosse & Karen Weck. 2010. Molecular Pathology of Hematolymphoid Diseases. Molecular Pathology of Hematolymphoid Diseases
277
285
.
Deborah A. Thomas, Susan O'Brien & Hagop M. Kantarjian. (2009) Monoclonal Antibody Therapy with Rituximab for Acute Lymphoblastic Leukemia. Hematology/Oncology Clinics of North America 23:5, pages 949-971.
Crossref
Crossref
Vaishalee P. Kenkre & Wendy Stock. (2009) Burkitt Lymphoma/Leukemia: Improving Prognosis. Clinical Lymphoma and Myeloma 9, pages S231-S238.
Crossref
Crossref
Jennifer L. Kelly, Stephen R. Toothaker, Lauren Ciminello, Dieter Hoelzer, Harald Holte, Ann S. LaCasce, Graham Mead, Deborah Thomas, Gustaaf W. Van Imhoff, Brad S. Kahl, Bruce D. Cheson, Ian T. Magrath, Richard I. Fisher & Jonathan W. Friedberg. (2009) Outcomes of Patients With Burkitt Lymphoma Older Than Age 40 Treated With Intensive Chemotherapeutic Regimens. Clinical Lymphoma and Myeloma 9:4, pages 307-310.
Crossref
Crossref
Kyung A. Choi, Jung Eun Lee, Yoon-Goo Kim, Dae Joong Kim, Kihyun Kim, Young Hyeh Ko, Ha Young Oh, Won Seog Kim & Wooseong Huh. (2008) Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome. Annals of Hematology 88:7, pages 639-645.
Crossref
Crossref
Graham M. MeadSharon L. BarransWendi QianJan WalewskiJohn A. Radford, Max Wolf, Simon M. ClawsonSally P. StenningClaire L. YuleAndrew S. Jack. (2008) A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood 112:6, pages 2248-2260.
Crossref
Crossref
Pilar Miralles, Juan Berenguer, José María Ribera Santasusana, Felipe Calvo, Joaquín Díaz Mediavilla, José Luis Díez-Martín, José Gomez Codina, José López Aldeguer, Rafael Rubio, Jesús Santos & Eulalia Valencia. (2008) Recomendaciones de GESIDA/PETHEMA sobre el diagnóstico y el tratamiento de los linfomas en pacientes infectados por el virus de la inmunodeficiencia humana. Medicina Clínica 130:8, pages 300-311.
Crossref
Crossref
Archibald S. Perkins & Jonathan W. Friedberg. (2008) Burkitt Lymphoma in Adults. Hematology 2008:1, pages 341-348.
Crossref
Crossref
Edwarda M. Buda-Okreglak, Michael J. Walden & Mark D. Brissette. (2007) Perineural CNS Invasion in Primary Cutaneous Follicular Center Lymphoma. Journal of Clinical Oncology 25:29, pages 4684-4686.
Crossref
Crossref
Joshua W. Knowles, Amy B. Elliott & Joshua Brody. (2007) A case of complete heart block reverting to normal sinus rhythm after treatment for cardiac invasive Burkitt’s lymphoma. Annals of Hematology 86:9, pages 687-690.
Crossref
Crossref
Jason T Yustein & Chi V Dang. (2007) Biology and treatment of Burkittʼs lymphoma. Current Opinion in Hematology 14:4, pages 375-381.
Crossref
Crossref
Pilar Miralles, Juan Berenguer, José María Ribera, Rafael Rubio, Beatriz Mahillo, María Jesús Téllez, José Lacruz, Eulalia Valencia, Jesús Santos, Francisco Rodríguez-Arrondo & Vicente Pintado. (2007) Prognosis of AIDS-Related Systemic Non-Hodgkin Lymphoma Treated With Chemotherapy and Highly Active Antiretroviral Therapy Depends Exclusively on Tumor-Related Factors. JAIDS Journal of Acquired Immune Deficiency Syndromes 44:2, pages 167-173.
Crossref
Crossref
Ian T. Magrath. (2006) Treatment of Burkitt lymphoma in children and adults: Lessons from Africa. Current Hematologic Malignancy Reports 1:4, pages 230-240.
Crossref
Crossref
Judith A. Ferry. (2006) Burkitt's Lymphoma: Clinicopathologic Features and Differential Diagnosis. The Oncologist 11:4, pages 375-383.
Crossref
Crossref
Conrad E. Johanson, John A. Duncan, Edward G. Stopa & Andrew Baird. (2005) Enhanced Prospects for Drug Delivery and Brain Targeting by the Choroid Plexus–CSF Route. Pharmaceutical Research 22:7, pages 1011-1037.
Crossref
Crossref
G W van Imhoff, B van der Holt, M A MacKenzie, G J Ossenkoppele, P W Wijermans, M H H Kramer, M B van 't Veer, H C Schouten, M van Marwijk Kooy, M H J van Oers, J M M Raemaekers, P Sonneveld, L A M H Meulendijks, P M Kluin, H C Kluin-Nelemans & L F Verdonck. (2005) Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia 19:6, pages 945-952.
Crossref
Crossref
Yvette L Kasamon & Lode J Swinnen. (2004) Treatment advances in adult Burkitt lymphoma and leukemia. Current Opinion in Oncology 16:5, pages 429-435.
Crossref
Crossref